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Introduction {#sec1}
============

Spinal muscular atrophy (SMA) is a common recessive genetic disease and is the leading genetic cause of infant mortality. For 98% of patients, SMA is caused by deletions or mutations in the *survival motor neuron* gene 1 (*SMN1*) ([@bib39], [@bib41]). The SMN protein is ubiquitously expressed and interacts with a large number of factors, indicating its involvement in multiple biological pathways.

The best-characterized function of the SMN complex is its role in the biogenesis of spliceosomal small nuclear ribonucleoprotein (snRNP) particles, which are major constituents of the spliceosome, the nuclear pre-mRNAs processing machinery ([@bib40], [@bib23], [@bib48], [@bib4], [@bib16]). Several studies have reported that SMN deficiency alters the stoichiometry of snRNPs in SMN-deficient mouse tissues and causes widespread and tissue-specific pre-mRNA splicing defects in SMA mouse models ([@bib26], [@bib64], [@bib5]). There is also evidence that SMN deficiency gives rise to differential defects and alterations in the splicing of various genes ([@bib8], [@bib42], [@bib20]). These results support the view that SMA might arise from the inefficient splicing of pre-mRNAs coding for proteins required for motor neurons function and/or survival. However, a non-splicing role is also possible, as axons contain SMN complexes lacking Sm proteins but containing other RNA-binding proteins, suggesting a function for SMN in the assembly of ribonucleoproteins involved in the regulation of mRNA transport, stability, and/or local translation ([@bib11], [@bib52], [@bib21]).

SMN also interacts with proteins associated with cytoskeletal dynamics ([@bib10], [@bib21]). Integrity of the cytoskeleton is essential for correct function of the synaptic terminal as well as for the axons, and several reports indicate that cytoskeletal dynamics might be impaired in SMA. Indeed, SMN was shown to interact and to co-localize in motor neurons with the small actin-binding proteins profilin I and II, and SMN knockdown induced a stronger interaction between profilin-2 and its upstream kinase ROCK ([@bib30], [@bib9], [@bib10]). Involvement of the actin cytoskeleton in SMA is also based on studies showing that the actin-bundling protein Plastin 3 acts as a protective modifier of SMA in humans ([@bib47]). Accordingly, *PLS3* overexpression rescues axon outgrowth defects in SMN-deficient zebrafish embryos, in cultured motor neurons, and in mouse models of SMA ([@bib47], [@bib31], [@bib1], [@bib37]). SMN deficiency resulted also in impaired endocytosis in various models of SMA including human, mice, zebrafish, C. elegans, or Drosophila ([@bib19], [@bib32], [@bib51], [@bib34]). Importantly, endocytosis defects can also be rescued by genetic modifiers such as *PLS3* ([@bib32]), *NCALD* ([@bib51]), and *CHP1* ([@bib34]).

As there is no SMN homolog in the budding yeast *Saccharomyces cerevisiae*, a detailed analysis of the SMN functions has never been possible using genetic and biochemical approaches in this model system. In contrast, the fission yeast *Schizosaccharomyces pombe* contains an SMN gene, which is essential for growth. In this work, we used a genetic approach to find genes able to modulate growth of fission yeast cells carrying a hypomorphic temperature-degron SMN (*tdSMN*) mutant, which has differential snRNP assembly and splicing defects ([@bib13]). We report that deletion of the *acp1*^*+*^ gene encoding a subunit of the heterodimeric actin-capping protein has a protective effect on this *tdSMN* mutant. We found also that *tdSMN* cells contain lower levels of profilin and have excessively polymerized and stable actin networks leading to delays in endocytosis, cytokinesis, and cellular growth. Our work provides a framework for understanding how actin dynamics might become altered in SMN-deficient cells.

Results {#sec2}
=======

The acp1^+^ Gene Is a Protective Modifier for SMN-deficient S. pombe Cells {#sec2.1}
--------------------------------------------------------------------------

To characterize biological pathways connected to SMN, we focused on a hypomorphic fission yeast *tdSMN* mutant displaying a growth defect even at the permissive temperature ([@bib13]). We took an Epistatic MiniArray Profiles (E-MAP) approach ([@bib17]) to screen for deletion strains that either enhance or suppress the tdSMN growth defect. As shown in [Table S1](#mmc1){ref-type="supplementary-material"}, we identified 10 hits with significant scores, which include four suppressors and six enhancers. Remarkably, the vast majority of the encoded proteins have human homologs ([Table S1](#mmc1){ref-type="supplementary-material"}). As expected and based on known links between splicing, chromatin structure, and transcription ([@bib44]), several identified genes have functions in chromatin remodeling, transcription, protein transport, and dephosphorylation. Further validation of the E-MAP screen was provided by identification of the deletion of the fission yeast *icln*^*+*^ gene, which encodes a subunit of the PRMT5-complex known to act with the SMN complex in early steps of snRNP biogenesis ([@bib43], [@bib15], [@bib3]), as an enhancer of tdSMN growth defect.

To decipher the molecular bases of the protective effects of modifier genes and due to potential links between deregulation of actin dynamics and SMA pathogenesis ([@bib47], [@bib10]), we focused on the protective/modifier gene *acp1*^*+*^ (actin-capping protein of muscle Z-line subunit alpha 1, *CAPZA1* in human), which together with *acp2*^*+*^, encodes the heterodimeric actin-capping protein (CP) binding to the fast growing barbed ends of actin filaments. Neither *acp1*^*+*^ nor *acp2*^*+*^ are required for cell viability, and *S*. *pombe* cells lacking either capping protein subunits have normal morphology at 25°C ([@bib45], [@bib38]). Throughout this work, we examined the effects of *tdSMN* and *acp1Δ* on cell growth, protein levels, and actin assembly at the permissive temperature (25°C) because tdSMN cells already display snRNP assembly, splicing, and growth defects at 25°C ([@bib13]). The suppressive phenotype of *acp1Δ* was confirmed by a growth assay using serial dilutions of wild-type, *tdSMN,* and *tdSMN acp1Δ* strains ([Figure S1](#mmc1){ref-type="supplementary-material"}A), which showed that the double mutant is slightly healthier than the single *tdSMN* strain. Growth curves also showed a slight improvement in growth upon deletion of *acp1*^*+*^ in the *tdSMN* background ([Figure S1](#mmc1){ref-type="supplementary-material"}B).

tdSMN Cells Contain Higher Levels of Filamentous Actin {#sec2.2}
------------------------------------------------------

To characterize the molecular basis explaining the protective effect of *acp1*^*+*^ deletion on the *tdSMN* mutant, we first characterized the filamentous/globular (F/G)-actin ratio in wild-type, *tdSMN,* and *tdSMN acp1Δ* strains. As shown in [Figure 1](#fig1){ref-type="fig"}A, when actin is prepared using NaOH/TCA treated extracts, the total amount of actin is similar in all three strains. However, when actin is prepared by differential centrifugation following the protocol of the cytoskeleton *in vivo* F/G-actin assay kit, we found that monomeric G-actin is barely detectable in all strains, whereas F-actin is easily detected and migrates similarly to control rabbit skeletal muscle actin as a 42 kDa protein ([Figure 1](#fig1){ref-type="fig"}A). Interestingly, quantification of the blot showed that F-actin is found at lower levels in the wild-type and *tdSMN acp1Δ* cells compared with *tdSMN* cells ([Figures 1](#fig1){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}).Figure 1Increased Levels of Filamentous Actin in *S*. *pombe* SMN-deficient Cells(A) Whole-cell extract and F/G-actin fractions were prepared as described in Experimental Procedures, and equal amounts of fractions for each strain were loaded onto SDS-PAGE gels. Immunoblot was done using the AAN01 actin antibody. Representative data from three independent experiments are shown. A lane containing 100 ng of rabbit skeletal muscle actin was included as control.(B) Changes in the levels of F-actin observed on blots were quantified using ImageJ. Data are from three independent experiments. Data are presented as mean ± SEM for each category. (\*\*) p \< 0.01, (\*) p \< 0.05, (ns) non-significant, Tukey\'s multiple comparison test.(C) Actin distribution in wild-type, *tdSMN,* and *tdSMN acp1Δ* suppressor cells. The cells were grown at 25°C, fixed with paraformaldehyde and stained for actin with Alexa Fluor 488 phalloidin. DNA was stained with DAPI (blue). Fluorescence was quantified using ImageJ from n \> 200 cells for each strain with three trials per genotype. Images were acquired using identical parameters. Data are presented as mean ± SEM for each category. (\*\*\*) p \< 0.001, (ns) non-significant, Tukey\'s multiple comparison test.(D) Actin distribution was examined in wild-type and *acp1Δ* cells in conditions similar to those described in 1C. Quantification was performed using ImageJ from n = 30 cells with three trials per genotype. (\*\*\*) p \< 0.001, two-sided unpaired Student *t* tests.(E) Latrunculin A sensitivity of strains. Cells were grown in YES media, and serial dilutions were spotted on YES plates containing no or the indicated concentrations of latrunculin A (LatA).

To confirm levels of F-actin in the strains, quantitative fluorescence microscopy was performed on fixed cells stained with Alexa Fluor 488 phalloidin, which is known to bind tightly and selectively to F-actin polymers. Stacks (z series) of images were acquired at high (63×) magnification, and one section was used to calculate the background-corrected total cell fluorescence (CTCF) from n \> 200 cells using ImageJ. Representative images of phalloidin staining are shown in [Figures 1](#fig1){ref-type="fig"}C and 1D as well as in [Figure S3](#mmc1){ref-type="supplementary-material"} for the strains that were grown exponentially under similar conditions. Quantification of the fluorescence intensity showed increased fluorescence in *tdSMN*, *tdSMN acp1Δ*, and *acp1Δ* cells compared with wild type ([Figures 1](#fig1){ref-type="fig"}C and 1D), indicating increased levels of F-actin.

We reasoned that higher levels of F-actin in the *tdSMN* mutant could have an impact on actin dynamics. To test this, we monitored the sensitivity of the strains to latrunculin A (LatA), which is a potent inhibitor of F-actin polymerization and has been shown to cause disruption of the actin cytoskeleton ([@bib25]). As shown in [Figure 1](#fig1){ref-type="fig"}E, all strains grew on rich media and were sensitive to 0.5 μM LatA. However, on plates containing lower amounts of LatA (0.1 μM), wild-type and *tdSMN* cells were resistant, whereas *tdSMN acp1Δ* and *acp1Δ* cells were hypersensitive. Remarkably, *tdSMN* cells were found to be considerably resistant to 0.3 μM LatA, whereas growth of wild-type, *tdSMN acp1Δ,* and *acp1Δ* cells was inhibited. Altogether, these experiments demonstrate that actin dynamics is altered in *tdSMN* cells and that the *tdSMN* mutant contains excessively polymerized actin compared with wild-type and suppressor cells.

Analysis of Actin Distribution In Vivo {#sec2.3}
--------------------------------------

To investigate actin dynamics in live cells, we constructed strains carrying a *Pact1*-LifeAct-GFP reporter, which allows visualization of the actin cytoskeleton in living cells ([@bib33]). Cells expressing this reporter resemble wild-type cells in morphology, growth rate, and cell division ([@bib33]), indicating that any effects of the reporter on actin dynamics are only subtle ([@bib18]). Expression levels of the LifeAct-GFP reporter were similar in wild-type, *tdSMN*, *tdSMN acp1Δ* suppressor, and *acp1Δ* cells ([Figure S4](#mmc1){ref-type="supplementary-material"}), and all four strains contained the three F-actin structures present in *S*. *pombe*: endocytic actin patches, cables, and contractile actin rings ([Figure 2](#fig2){ref-type="fig"}A). There were clear similarities in the distribution of F-actin in wild-type, *tdSMN acp1Δ*, and *acp1Δ* cells, with all three strains having more bipolar actin and fewer cells with contractile actin rings ([Figure 2](#fig2){ref-type="fig"}B). In contrast, the actin patches in *tdSMN* cells often had a monopolar distribution, and the number of *tdSMN* cells containing bipolar actin decreased two-fold. There were also more *tdSMN* cells with actin localized at the contractile actin ring compared with wild-type, suppressor, and *acp1Δ* cells ([Figure 2](#fig2){ref-type="fig"}B). As shown in [Figure 2](#fig2){ref-type="fig"}C, wild-type and *acp1Δ* monopolar cells had a homogeneous size around 8 μm, whereas *tdSMN* cells were more heterogeneous with elongated cells reaching 15 μm or more, and the sizes of *tdSMN acp1Δ* suppressor cells were more similar to wild-type cells and *acp1Δ* cells. Of the cells with actin localized at the cytokinetic ring, *tdSMN* cells were twice as long compared with wild type, whereas the size of the suppressor cells is between that of wild-type and *tdSMN* cells ([Figures 2](#fig2){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}). Altogether, these results indicate that *tdSMN* cells have defective actin localization and delayed cytokinesis, which can be partially restored by deletion of the *acp1*^*+*^ gene.Figure 2Cytokinesis Defect of *tdSMN* Mutant Cells(A) Comparison of LifeAct-GFP-labeled F-actin structures in wild-type, *tdSMN*, *tdSMN acp1Δ* suppressor, and *acp1Δ* cells. Fluorescence micrographs show that the *S*. *pombe* actin networks are observed in all four strains. The bar represents 3 μm.(B) Quantification of (A) showing the percentage of cells with corresponding actin distribution for each indicated strain. Monopolar, actin localized at one end; bipolar, actin at both ends; cytokinesis, actin localized at the cytokinetic ring. Data are represented as the mean from three separate experiments (n = 100) with error bars showing the SD.(C) Quantification of (A) showing the percentage of cells with corresponding cell sizes (in μm) for cells having actin localized as monopolar, bipolar, or at the cytokinetic ring. Results are from three independent measurements (n = 100). Quantification data are also shown as histograms in [Figure S5](#mmc1){ref-type="supplementary-material"}.

tdSMN Cells Display Splicing Defects in the Profilin Gene {#sec2.4}
---------------------------------------------------------

Actomyosin ring formation is a highly complex and dynamic process requiring actin remodeling and de novo actin assembly at the division site ([@bib50], [@bib59]). This actin remodeling is orchestrated by actin-binding proteins including profilin (*cdc3*^*+*^), cofilin (*adf1*^*+*^), and coronin (*crn1*^*+*^). Given that the *S*. *pombe* genes coding for these regulators contain introns and due to the snRNP assembly and splicing defects observed in the hypomorphic *tdSMN* mutant ([@bib13]), we wondered whether genes coding for these actin-binding proteins might be mis-spliced. Splicing of those three genes were thus analyzed by RT-PCR and as shown in [Figure 3](#fig3){ref-type="fig"}A, strong splicing defects can be observed for profilin with clear accumulation of pre-messenger RNAs and a decrease in the level of mature messenger (mRNA) both in the *tdSMN* mutant and *tdSMN acp1Δ* suppressor cells but not in *acp1Δ* cells ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In contrast, no significant splicing defects could be found for cofilin and coronin genes ([Figures 3](#fig3){ref-type="fig"}B and 3C, respectively). The decrease in the level of mature profilin mRNA leads to about 80% decrease in the level of profilin protein in *tdSMN* and *tdSMN acp1Δ* cells as measured by Western blot analysis using antibodies directed against *S*. *pombe* profilin ([Figures 3](#fig3){ref-type="fig"}D and 3E).Figure 3Fission Yeast SMN-deficient Cells Display Splicing Defects in the Profilin Gene(A--C) RT-PCR analyses were performed on total RNA isolated from the wild-type, *tdSMN* mutant, and *tdSMN acp1Δ* suppressor grown at 25°C. The PCR products were separated on a 1.5% agarose gel and visualized by ethidium bromide staining. Tests were performed for introns located in the *S*. *pombe cdc3*^*+*^ gene coding for profilin (A), the *adf1*^*+*^ gene coding for cofilin (B), and the *crn1*^+^ gene coding for coronin (C). The marker corresponds to the invitrogen 1Kb Plus DNA ladder.(D) Western blot of extracts prepared from the indicated strains using antibodies directed against *S*. *pombe* profilin. For loading control, GAPDH levels were determined.(E) Quantification of (D) with three trials, with error bars showing the SD.(F) Live-cell GFP images of Crn1-GFP fusion in wild-type, *tdSMN* mutant, *tdSMN acp1Δ* suppressor, and *acp1Δ* cells. DNA was stained with DAPI (blue). See [Figure S7](#mmc1){ref-type="supplementary-material"} for representative images.(G) Quantification of intensity (a) (n = 30) and lifetime (b) (n = 20) of endocytic Crn1-GFP patches. Data are presented as dot plots with mean. ns (non-significant), \*\*\* (p \< 0.001), and \*\* (p \< 0.01) represent statistical significance as determined by ANOVA with Tukey\'s post-hoc test.

Increased Crn1-GFP Fluorescence and Lifetime of Endocytic Patches in tdSMN acp1Δ Suppressor Cells {#sec2.5}
-------------------------------------------------------------------------------------------------

As mentioned above, profilin, cofilin, and coronin are important molecules for actin-filament remodeling and disassembly. In order to investigate localization of these proteins, we tried to construct tagged versions of the genes by inserting epitopes using homologous recombination. We were unable to obtain tagged genes for profilin and cofilin, and this is due to the fact that the tagged fusion genes are not functional ([@bib63], [@bib46]). However, we obtained a strain carrying a coronin-GFP fusion gene expressed from its endogenous promoter. As shown by Western blot using anti-GFP antibodies, expression of the fusion protein is similar in wild-type, *tdSMN*, *tdSMN acp1Δ* suppressor, and *acp1Δ* strains ([Figure S6](#mmc1){ref-type="supplementary-material"}). It has been previously reported that Crn1-GFP localizes in patches that are coincident with actin ([@bib56]). Accordingly, Crn1-GFP fluorescence can be observed as patches at the cell tips as well as at the cell division sites in all three strains ([Figures 3](#fig3){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}). We quantified coronin fluorescence in live cells as a measure of actin accumulation in endocytic patches, and we found that levels of Crn1-GFP are increased in *tdSMN acp1Δ* suppressor and in *acp1Δ* cells ([Figure 3](#fig3){ref-type="fig"}G, panel a). Moreover, although identical in wild-type and *tdSMN* cells, the lifetime of patches is also increased in *tdSMN acp1Δ* and *acp1Δ* cells ([Figure 3](#fig3){ref-type="fig"}G, panel b). Consistent with studies showing that deletion of *acp1*^*+*^ increases the peak amount of actin in endocytic patches ([@bib6]), our results indicate that endocytic patches in *tdSMN acp1Δ* suppressor and *acp1Δ* cells might contain higher levels of coronin and actin compared with wild-type and *tdSMN* cells.

Deletion of acp1^+^ in the tdSMN Mutant Rescues Partially the Endocytic Process {#sec2.6}
-------------------------------------------------------------------------------

Because defects in actin dynamics result in perturbations of endocytosis ([@bib28]), we measured endocytosis using an internalization assay with FM4-64, an amphiphilic fluorescent dye entering cells through endocytosis ([@bib60]). To examine the transport of FM4-64, cells were first incubated with the dye on ice and then chased at 25°C for various times. As shown in [Figures 4](#fig4){ref-type="fig"}A and 4B, the dye is transported efficiently into wild-type and *acp1Δ* cells. It is also incorporated in the suppressor cells, whereas in *tdSMN* cells, labeling is highly decreased even after 30 min. Quantification analyses ([Figure 4](#fig4){ref-type="fig"}C) confirm that FM4-64 was internalized more slowly in *tdSMN* cells, suggesting that endocytosis is altered in the *tdSMN* hypomorphic mutant. They show also that deletion of *acp1*^*+*^ rescues partly the endocytic process in the *tdSMN acp1Δ* suppressor cells.Figure 4Fission Yeast SMN-deficient Cells Display an Endocytosis Defect(A and B) Analysis of endocytosis was performed for the indicated strains using the lipophilic dye, FM4-64. After incubation with FM4-64 on ice for the indicated time, cells were transferred to an imaging chamber, and images were captured in a single focal plan and the light intensity recorded for 20 cells at each time point. Representative images of cells are shown. Scale bars represent 4 μm.(C) Quantification of (A) and (B). Data are represented as the mean ± SEM from three separate experiments (n = 20).

Discussion {#sec3}
==========

Yeast models have been proven to be relevant research tools to study biological pathways and to identify components and mechanisms of many essential cellular processes. They have also been used for identifying the functions of genes related to human diseases, including neurodegenerative diseases (for review, see [@bib24]). In this work, using *S*. *pombe*, we demonstrate a clear correlation between an impaired function of SMN in snRNP assembly and defects in actin dynamics. We show that SMN deficiency gives rise to splicing defects in the profilin gene leading to decreased cellular levels of profilin. No interaction could be detected between *S*. *pombe* SMN and profilin by two-hybrid assays ([Figure S8](#mmc1){ref-type="supplementary-material"}), indicating that the observed splicing defects are responsible for the alteration of actin dynamics in the *tdSMN* mutant. Indeed, profilins constitute a family of small monomeric G-actin-binding proteins that are structurally highly conserved and essential for the regulation of filamentous F-actin networks ([@bib36]). In both mammalian and yeast cells, overproduction of profilin enhances linear actin arrays and inhibits short-branched actin networks, whereas lower level of profilin favors such branched actin patches ([@bib12], [@bib58], [@bib53]). It is also known that modifying profilin levels alters specific F-actin networks and leads to defects in cytokinesis in various cells including fission yeast, worms, and mice ([@bib2], [@bib54], [@bib62]). Our results are thoroughly consistent with profilin being required for proper distribution of actin to different homeostatic F-actin networks ([@bib59], [@bib50], [@bib14]).

As splicing of profilin is not rescued by deletion of *acp1*^*+*^, the *acp1Δ* modifier/protective effect is likely downstream. Accordingly, the heterodimeric capping protein binds to free F-actin barbed-ends with high affinity ([@bib61], [@bib55]) and competes also with other barbed-ends regulators such as formins ([@bib38]) or Aip1 ([@bib6]). It is also known that binding of profilin to barbed-ends enhances the dissociation of actin from barbed ends and thus destabilizes the actin filaments ([@bib35], [@bib49]). Our results are consistent with these observations and support the model for actin dynamics depicted in [Figure 5](#fig5){ref-type="fig"}. In this model, due to decreased levels of profilin in the *tdSMN* mutant, profilin is unable to compete with proteins binding to barbed ends including the capping protein, which can therefore bind to excessive numbers of barbed ends, enhancing stabilization of actin filaments. As a consequence, the pool of actin available for the formation of new actin networks is low, and this generates the endocytosis and cytokinesis delays observed in the *tdSMN* mutant. Upon deletion of the *acp1*^+^ gene in *tdSMN* cells, the capping protein is not functional enabling actin depolymerization from barbed ends. This refills the pool of polymerizable actin restoring actin turnover/distribution to other networks and alleviates partially the *tdSMN* growth defect. The *tdSMN acp1Δ* suppressor exhibits also increased binding of coronin as shown by enhanced fluorescence of actin patches in cells expressing an endogenous Crn1-GFP reporter ([Figure 3](#fig3){ref-type="fig"}G). Because it has been reported that coronin cooperates with actin-binding regulators to sever older filaments ([@bib29]), the suppressive mechanism of *acp1*^*+*^ deletion in the *tdSMN* background could indeed be due to increased availability of actin molecules. Our results are in agreement with the view that profilin orchestrates actin homeostasis and with the emerging notion that competition for limited amounts of actin monomers represents an important regulatory mechanism for the organization of actin cytoskeletal networks and for cellular growth ([@bib59], [@bib50], [@bib14]).Figure 5Model of Actin Dynamics in *S*. *pombe* Wild-Type, *tdSMN* Mutant, and *tdSMN acp1Δ* Suppressor CellsUpper panel: correct actin turnover is achieved in wild-type cells because profilin can compete with the functional capping protein, for binding to barbed ends of actin filaments. Middle panel: in the *tdSMN* mutant, defective splicing downregulates profilin, which perturbs actin turnover by allowing excessive binding of capping protein. Lower panel: deletion of the acp1 subunit of the capping protein in the *tdSMN* mutant removes functional capping protein and thus restores actin dynamics by allowing depolymerisation of actin from barbed ends. This generates increased redistribution of actin monomer to the different actin networks. Pointed (−) and barbed (+) ends are indicated. See also [Discussion](#sec3){ref-type="sec"} for details.

Our work shows also that *tdSMN* cells contain extensively polymerized actin networks, which are more resistant to depolymerization as shown by increased growth on plates containing LatA ([Figure 1](#fig1){ref-type="fig"}E). Although F-actin dynamics and localization are also impaired in SMA mouse models ([@bib1], [@bib27]), it is interesting to note that levels of F-actin are significantly reduced upon SMN knockdown at the presynaptic site at the NMJ structure as well as in NSC34 and HEK293T cells ([@bib1], [@bib32]). As depicted in [Figure 6](#fig6){ref-type="fig"}, this apparent contradiction in the amounts of F-actin found in the S. pombe *tdSMN* mutant and SMA cells could be explained by the fact that splicing defects of an unidentified actin regulator, different of profilin, might be responsible for the observed alterations in actin dynamics in mammalian models of SMA. According to this view, defective splicing has never been observed for profilin genes in studies aimed to characterize splicing defects in mammalian SMA models ([@bib64], [@bib5], [@bib42]).Figure 6Schematic Depiction of Events Leading to Alterations and Rescues of Actin Dynamics in SMN-deficient *S*. *pombe* and Mammalian SMA ModelsIn the *tdSMN* mutant, due to splicing defects, profilin levels are decreased, giving rise to higher levels of F-actin and altering actin dynamics. Correct actin dynamics can be restored by deletion of the *acp1*^*+*^ gene. For SMA in mammals, we propose that splicing defects lead to decreased levels of an unidentified actin regulator, and this results in lower levels of F-actin and alterations in actin dynamics, which can be suppressed by overexpression of *PLS3* or *CORO1C* ([@bib32], [@bib37]).

A stabilized actin network could also explain the observed perturbation of the endocytic pathway in *tdSMN* cells ([Figure 4](#fig4){ref-type="fig"}). As already mentioned in the [Introduction](#sec1){ref-type="sec"}, defects in endocytosis were also observed when SMN levels were compromised in various SMA models ([@bib19], [@bib32], [@bib51], [@bib34]). In mice particularly, it has been shown that endocytic defects can be restored by overexpression of Plastin 3 or Coronin 1C, which are F-actin-binding and -bundling proteins. Remarkably, the capping protein was also co-immunoprecipitated from *PLS3*-overexpressing HEK293T cells, indicating that it is part of a unique functional complex ([@bib32]). It is thus possible that restoration of actin dynamics might also represent the mechanism leading to the rescue of endocytic trafficking observed in SMA mice.

Several studies have also identified mutations in the *PFN1* gene in human familial amyotrophic lateral sclerosis (ALS) patients ([@bib57]). Accordingly, novel mouse models carrying profilin-1 mutations show abnormal F/G-actin ratio in spinal cords and have physical and mental ALS-like phenotypes ([@bib22]). Given that cytoskeletal defects in the brain and spinal cord tissues emerge as one of the most important causes of motor neuron vulnerability, it is tempting to speculate that SMA could also be caused by splicing alterations in genes playing a role in actin dynamics ([Figure 6](#fig6){ref-type="fig"}). In this regard, a recent transcriptomic study has reported a significant downregulation of the axon-guidance pathway in spinal cords of postnatal day 5 SMA mice ([@bib20]). This is particularly intriguing because formation of axons is dependent on crosstalks between actin filaments and the microtubule cytoskeleton ([@bib7]). Future work will be necessary to define precisely the splicing pattern of many attractive candidates including genes coding for the various actin-binding partners, many isoforms being implicated in the assembly of different actin cellular structures.

Limitations of the Study {#sec3.1}
------------------------

Our study shows that splicing defects in the profilin gene occur in the fission yeast *tdSMN* hypomorphic mutant and lead to alterations in actin dynamics. However, given that splicing capabilities are lowered in *tdSMN* cells, it is likely that additional splicing defects take place in other pre-mRNAs, indicating that multiple cellular processes might be affected in the *tdSMN* mutant. Moreover, the direct relevance of this work to SMA disease progression remains to be determined using *in vivo* studies in mammalian systems.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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